CAR T-Cell Therapy Market size worth $ 51408.40 Million, Globally, by 2028 at 63.82% CAGR: Verified Market Research®

Due to the rising incidence of cancer across the globe, increasing research and development by key players in the CAR T-Cell Therapy, increased government activities for cancer awareness and other factors will lead to growth of the market.

JERSEY CITY, N.J. , June 1, 2022 /PRNewswire/ --  Verified Market Research recently published a report, "CAR T-Cell Therapy Market" By Targeted Antigen (CD 19, HER1), By Therapeutic Application (Acute Lymphocytic Leukemia, Colorectal Cancer), and By Geography. According to Verified Market Research, CAR T-Cell Therapy Market size was valued at USD 589.99 Million in 2020 and is projected to reach USD 51408.40 Million by 2028, growing at a CAGR of 63.82% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=55317

Browse in-depth TOC on "CAR T-Cell Therapy Market"

202 - Pages 
126 – Tables 
37 – Figures

Global CAR T-Cell Therapy Market Overview

The global CAR T-Cell Therapy Market is predicted to develop in response to the rising incidence of cancer and the rising number of patients who have failed to respond to alternative treatments. Additionally, rising public awareness about healthcare and wellbeing, changing illness patterns, government backing, and increasing volumes of T-Cell therapy applications in various cancer research institutions are likely to fuel the market's expansion. Furthermore, the industry is being fueled by rising government programs aimed at enhancing healthcare infrastructure and encouraging cancer-cell treatment research.

However, concerns about the cell therapy's negative effects and other neurological issues are predicted to impede the market growth. Also, the lack of demand for therapy is one of the key constraints that industry players confront. The target audience is excessively strict and only understands native treatment methods. Furthermore, the accompanying treatment cost is very high, which does not sit well with the people because they come from various income categories and have diverse spending capacities. The global CAR T-Cell Therapy Market trends and operations are likely to pose major restraints for the market if costs and prices are not reduced, preventing the market from growing as predicted by industry leaders and CAR T-Cell Therapy Market experts during the forecast period.

Key Developments

• In February 2022, CARsgen announced that they open a new U.S. cGMP Facility for CAR-T production. CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.
• In December 2021, Novartis announced to launch T-Charge, a next-generation CAR-T platform with first-in-human data at ASH 2021.

Key Players

The major players in the market are CARsgen Therapeutics, Ltd., Novartis International AG, Pfizer, Inc., Kite Pharma, Inc., Legend Biotech, Juno Therapeutics, Aurora Biopharma Inc., Bluebird Bio, Inc., Mustang Bio, Inc., and Sorrento Therapeutics Inc.

Verified Market Research has segmented the Global CAR T-Cell Therapy Market On the basis of Targeted Antigen, Therapeutic Application, and Geography.

• CAR T-Cell Therapy Market, By Targeted Antigen
•  CD 19
• HER1
• BCMA
• CD33
• Others
• CAR T-Cell Therapy Market, By Therapeutic Application
• Acute Lymphocytic Leukemia
• Colorectal Cancer
• Chronic Lymphocytic Leukemia
• Hepatocellular Carcinoma
• Others
• CAR T-Cell Therapy Market, by Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

Branded Generics Market By Type (Trade Named Generics, and Value-Added Branded Generics), By Distribution Channel (Pharmacy, Hospital, Clinics), By Application (Cardiovascular Drugs, CNS Drugs, Anti-Infective Drugs, Anti-Cancer Drugs), By Geography, Forecast, 2021-2028

Cancer Immunotherapy Market By Technology Type (Monoclonal Antibodies, Cytokines and Immunomodulators), By Application (Prostate cancer, Breast Cancer), By End-User (Hospitals and Clinics, Cancer Research Centers), By Geography, Forecast, 2021-2028

Cancer/Tumor Profiling Market By Technology (Sequencing Technique, Next-Generation Sequencing (NGS)), By Type (Genomics, Metabolomics), By Application (Research Applications, Clinical Applications), By Geography, Forecast, 2021-2028

Standalone Cancer Registry Software Market By Product (Public Database, Commercial Database), By Application (Hospitals, Healthcare Providers, Research Centers), By Geography, Forecast, 2021-2028

Top 9 Cancer Immunotherapy Companies supporting infirmaries to fight against cancer

Visualize CAR T-Cell Therapy Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes 
Verified Market Research® 
US: +1 (650)-781-4080 
UK: +44 (753)-715-0008 
APAC: +61 (488)-85-9400 
US Toll Free: +1 (800)-782-1768 
Email: [email protected] 
Web: https://www.verifiedmarketresearch.com/ 
Follow Us: LinkedIn | Twitter

SOURCE Verified Market Research